Increasing HCV Knowledge & Service Use in Drug Tx Pgms

增加丙肝知识

基本信息

项目摘要

(Revised Abstract) DESCRIPTION: This is a competing continuation application for our current NIDA-funded study, "HCV Service Innovations in Drug Treatment Programs." It is proposed as a direct result of data collected from patients, staff, and managers in drug treatment programs who report that the hepatitis C virus (HCV) education provided to patients and staff is often inadequate, and HCV services are seriously underutilized. This is especially unfortunate because of the high prevalence of HCV among drug users, especially those co-infected with HIV, and their pressing need for information about, and services for HCV. Drug treatment programs are uniquely situated to educate, counsel, and test drug users for HCV and HIV, and facilitate their access to medical treatment. However, there are gaps in drug treatment programs' current provision of HCV services, and patients often don't use the limited services that do exist. Because communication with staff can affect patients' health behaviors, staff's encouragement of the use of existing HCV services is essential. Few staff, however, know what to tell patients about HCV, how to help them deal with test results, and how to counsel them about medical treatment. The need is especially great when dealing with patients co-infected with HIV and HCV, whose medical management is significantly more complicated because of the dual infection. By addressing the expressed need of treatment staff for an evidence-based HCV training, this study will assess whether such a training can improve staff's HCV and HCV/HIV knowledge, attitudes, intentions and behaviors, and if so, whether it will lead to benefits to patients and the drug treatment organization. Guided by Social Cognitive Theory and the Information-Motivation-Behavioral Skills Model, the Specific Aims are therefore: (1) To develop a staff intervention that includes current HCV information and training in how to best communicate with patients about HCV and HIV/HCV co-infection issues; (2) To examine the intervention's impact over time on staff's knowledge about HCV and HCV/HIV co-infection, and their attitudes, self-efficacy, intentions and behaviors to encourage their patients to use HCV services; and (3) To examine the impact of the intervention over time on: (a) Patients' HCV/HIV knowledge, attitudes, intentions, and actual use of HCV services; and on (b) The drug treatment organization's intentions toward, and actual expansion of HCV services, as well as its climate toward dealing with HCV and HCV/HIV co-infection. The intervention will be delivered to staff in 24 drug treatment programs in the four U.S. census regions, equally divided among drug-free and methadone programs: 16 programs will be randomly assigned to an intervention condition, and 8 to a control group (delayed intervention). The intervention's effectiveness will be examined by analyzing qualitative and quantitative data collected from the director, staff, and patients in the intervention and control condition programs. In its manualized form, successful elements of the training will be disseminated to programs nationwide
(修订摘要)描述:这是一个竞争的继续申请,我们目前的国家免疫缺陷署资助的研究,“丙型肝炎病毒服务创新药物治疗计划。“这是从药物治疗项目中的患者,工作人员和管理人员收集的数据的直接结果,他们报告说,向患者和工作人员提供的丙型肝炎病毒(HCV)教育往往不足,HCV服务严重未得到充分利用。这是特别不幸的,因为HCV在吸毒者中的高流行率,特别是那些合并感染艾滋病毒的人,他们迫切需要有关HCV的信息和服务。 药物治疗计划是唯一的定位,教育,咨询和测试吸毒者的HCV和HIV,并促进他们获得医疗。然而,药物治疗计划目前提供的HCV服务存在差距,患者往往不使用现有的有限服务。由于与工作人员的沟通会影响病人的健康行为,工作人员的鼓励使用现有的HCV服务是必不可少的。然而,很少有工作人员知道如何告诉患者有关HCV的信息,如何帮助他们处理检测结果,以及如何为他们提供医疗咨询。在处理同时感染艾滋病毒和丙型肝炎病毒的患者时,这种需要尤其重要,因为双重感染使其医疗管理更加复杂。通过解决治疗人员对循证HCV培训的表达需求,本研究将评估这种培训是否可以改善工作人员的HCV和HCV/HIV知识,态度,意图和行为,如果是这样,它是否会导致患者和药物治疗组织的利益。因此,在社会认知理论和信息-动机-行为技能模型的指导下,具体目标是:(1)制定一项工作人员干预措施,包括当前的HCV信息和培训如何最好地与患者就HCV和HIV/HCV合并感染问题进行沟通;(2)研究干预对医务人员HCV和HCV/HIV共感染知识、态度、自我效能、(3)研究干预措施对以下方面的影响:(a)患者的HCV/HIV知识、态度、意向和实际使用HCV服务的情况;以及(B)药物治疗组织对HCV服务的意图和实际扩展,以及其对处理HCV和HCV/HIV合并感染的气候。干预将提供给美国四个人口普查地区的24个药物治疗项目的工作人员,在无毒品和美沙酮项目中平均分配:16个项目将被随机分配到干预条件,8个项目被随机分配到对照组(延迟干预)。干预的有效性将通过分析从干预和控制条件计划中的主任、工作人员和患者收集的定性和定量数据来检查。 培训的成功要素将以手册的形式传播到全国各地的方案中

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHIELA M STRAUSS其他文献

SHIELA M STRAUSS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHIELA M STRAUSS', 18)}}的其他基金

Novel Interdisciplinary Intra-Oral Diabetes Screening in Dental Patients
牙科患者的新型跨学科口腔内糖尿病筛查
  • 批准号:
    8433603
  • 财政年份:
    2012
  • 资助金额:
    $ 58.87万
  • 项目类别:
Statistics & Data Analysis
统计数据
  • 批准号:
    7513824
  • 财政年份:
    2007
  • 资助金额:
    $ 58.87万
  • 项目类别:
SUPPORTING ALCOHOL REDUCTION IN HIV+ PATIENTS: A TRAINING FOR HIV CARE PROVIDERS
支持艾滋病毒患者减少饮酒:针对艾滋病毒护理人员的培训
  • 批准号:
    7230797
  • 财政年份:
    2006
  • 资助金额:
    $ 58.87万
  • 项目类别:
SUPPORTING ALCOHOL REDUCTION IN HIV+ PATIENTS: A TRAINING FOR HIV CARE PROVIDERS
支持艾滋病毒患者减少饮酒:针对艾滋病毒护理人员的培训
  • 批准号:
    7295818
  • 财政年份:
    2006
  • 资助金额:
    $ 58.87万
  • 项目类别:
HCV SERVICE INNOVATIONS IN DRUG TREATMENT PROGRAMS
药物治疗计划中的丙肝服务创新
  • 批准号:
    6619693
  • 财政年份:
    2001
  • 资助金额:
    $ 58.87万
  • 项目类别:
HCV SERVICE INNOVATIONS IN DRUG TREATMENT PROGRAMS
药物治疗计划中的丙肝服务创新
  • 批准号:
    6515782
  • 财政年份:
    2001
  • 资助金额:
    $ 58.87万
  • 项目类别:
Increasing HCV Knowledge & Service Use in Drug Tx Pgms
增加丙肝知识
  • 批准号:
    7253293
  • 财政年份:
    2000
  • 资助金额:
    $ 58.87万
  • 项目类别:
HCV SERVICE INNOVATIONS IN DRUG TREATMENT PROGRAMS
药物治疗计划中的丙肝服务创新
  • 批准号:
    6166798
  • 财政年份:
    2000
  • 资助金额:
    $ 58.87万
  • 项目类别:
HCV SERVICE INNOVATIONS IN DRUG TREATMENT PROGRAMS
药物治疗计划中的丙肝服务创新
  • 批准号:
    6379060
  • 财政年份:
    2000
  • 资助金额:
    $ 58.87万
  • 项目类别:
Increasing HCV Knowledge & Service Use in Drug Tx Pgms
增加丙肝知识
  • 批准号:
    6923959
  • 财政年份:
    2000
  • 资助金额:
    $ 58.87万
  • 项目类别:

相似海外基金

Post-genomic surveillance for communicable disease control
传染病控制的后基因组监测
  • 批准号:
    nhmrc : GNT1123879
  • 财政年份:
    2017
  • 资助金额:
    $ 58.87万
  • 项目类别:
    Career Development Fellowships
Post-genomic surveillance for communicable disease control
传染病控制的后基因组监测
  • 批准号:
    nhmrc : 1123879
  • 财政年份:
    2017
  • 资助金额:
    $ 58.87万
  • 项目类别:
    Career Development Fellowships
Strategies for communicable disease control in Aborigin al Australians
澳大利亚原住民传染病控制策略
  • 批准号:
    nhmrc : 932074
  • 财政年份:
    1993
  • 资助金额:
    $ 58.87万
  • 项目类别:
    NHMRC Project Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了